Where does Noble House Group PTY. Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Noble House Group PTY. Ltd. ranks #36,719 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Noble House Group PTY. Ltd. hold?

Noble House Group PTY. Ltd. holds 7 US utility patents granted between 2016 and 2023, spanning 8 technology areas.

What is Noble House Group PTY. Ltd.'s Innovation Score?

Noble House Group PTY. Ltd. has an Innovation Score of 40.0 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Noble House Group PTY. Ltd. focus on?

Noble House Group PTY. Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 5 patents. Grants appear in 8 CPC subclasses total.

Is Noble House Group PTY. Ltd.'s patent grant rate increasing or decreasing?

Noble House Group PTY. Ltd.'s recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Noble House Group PTY. Ltd.'s patents?

Noble House Group PTY. Ltd.'s patents average 21.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Noble House Group PTY. Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Noble House Group PTY. Ltd.

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Noble ranks #36,719 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#36,719
of 49,997 US assignees by volume: Top 37%
by Innovation Score (40.0/100): 21.4
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R36719 · Foreign Corporation #36,719 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #36,719/49,997
PHOTO-FINISH Nlightning Technology
CPC-NARROW A61B · 8 areas
INNOV-PAR 40.0/100
CLAIMS-DENSE 21.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nlightning Technology Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Noble House Group PTY · this assignee

40
3D Lighting… · lowest

7

What this shows Noble's Innovation Score is 40.0/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Noble's grants concentrate

Noble House Group PTY. Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 71.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2016. By volume, Noble sits between Nlightning Technology Ltd. and Normalu.

Noble's three-year grant acceleration

Noble House Group PTY. Ltd. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nlightning Techno…

7
NMI Naturwissensc…

7
No-knob

7
NO 59 Institute O…

7
Nohmi Bosai

7
Nomadd Desert Sol…

7
Nord-lock Switzer…

7
Normalu

7
Noble House Group… ◀

7

What this shows Noble holds 7 patents at rank #36,642, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Noble

By rank, the assignees closest to #36,642 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Noble's primary technology class.

Noble's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Noble House Group PTY. Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	14.3%
2017	1	14.3%
2019	1	14.3%
2020	1	14.3%
2022	2	28.6%
2023	1	14.3%

Which technologies does Noble House Group PTY. Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 3

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

F41B - Weapons FOR Projecting Missiles Without USE OF Explosive OR Combustible Propellant CHARGE; Weapons NOT Otherwise Provided FOR 1

A44B - Buttons, Pins, Buckles, Slide Fasteners, OR THE Like 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#36,719

of 49,997 tracked assignees

Innovation Score

40.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Noble House Group PTY. Ltd.'s patent record in context - here's where to go next.

Noble House Group PTY. Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 71.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #36,719 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Noble House Group PTY. Ltd. against Nlightning Technology Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.